<DOC>
	<DOCNO>NCT00272961</DOCNO>
	<brief_summary>The study determine safe effective dose TBC3711 patient uncontrolled high blood pressure already take blood pressure medication .</brief_summary>
	<brief_title>A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure .</brief_title>
	<detailed_description>The study stop due Pfizer ( sponsor ) decision compound would involve clinical development indication resistant hypertension 05 August 2008 . This decision base safety efficacy concern .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>N- ( 2-acetyl-4,6-dimethylphenyl ) -3- ( 3,4-dimethylisoxazol-5-ylsulfamoyl ) thiophene-2-carboxamide</mesh_term>
	<criteria>Diagnosis resistant hypertension . A stable antihypertensive drug regimen least 30 day . Sustained blood pressure great equal 180/120 mmHg . Required use thigh cuff blood pressure reading . Uncontrolled diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>